Article Sidebar

download PDF
 Open Access
Published:
Mar 11, 2014
DOI:
10.4314/ahs.v14i1.34

Article Details

Issue
Vol. 14 No. 1 (2014)
Section
Articles
A.    AFRICAN HEALTH SCIENCES OPEN ACCESS POLICY

While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:

  1. 1.      Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
  2. 2.      The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
  • No substantive errors are introduced in the process
  • Attribution of authorship and correct citation details are given
  • The referencing details are not changed.

Should the papers be reproduced in part, this must be clearly stated.

  1. 3.      The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.

B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences

I submitted my manuscript to African Health Sciences and would like to affirm that:

1.0  I am authorized by my co-authors to enter into these arrangements.

2.0 I guarantee, on behalf of self and co-authors:

  • That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights

 

  • That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation

 

  • That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published

 

  • That I/we have taken care to ensure the integrity of the article.

3.0  I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)

Author Biographies

Ahmet Karatas

Assistant Professor in Obstetrics and Gynecology

Recep Eroz

Assistant Professor in Medical Genetics

Mustafa Albayrak

Assistant Professor in Obstetrics and Gynecology

Tulay Ozlu

Assistant Professor in Obstetrics and Gynecology

Bulent Cakmak

Assistant Professor in Obstetrics and Gynecology

Fatih Keskin

Resident in Obstetrics and Gynecology

Main Article Content

Evaluation of Chromosomal Abnormalities and Common Trombophilic Mutations in Cases with Recurrent Miscarriage


Ahmet Karatas
Recep Eroz
Mustafa Albayrak
Tulay Ozlu
Bulent Cakmak
Fatih Keskin

Abstract

Background: Recurrent miscarriage (RM) is a frequent obstetric problem. Its’ pathophysiology is poorly understood. Infections, genetic, endocrine, anatomic and immunologic problems have been suggested as causes for RM. Objective: To evaluate the frequency of chromosomal abnormalities and 3 common thrombophilic mutations in couples with RM. Methods: A retrospective data collection was performed for the results of the cytogenetic analysis of the couples and Methylenetetrahydrofolate Reductase (MTHFR) C677T, Factor V Leiden (FVL) G1691A and Prothrombin (PTm) G20210A mutations of the mother in 142 couples suffering from RM. Results: Prevalence of FVL, MTHFR, and PTm gene mutations were similar between cases shaving 2 or ≥3 abortions (P=0.528; P=0.233; P=0.375). In patients with FVL, MTHFR and PTm gene mutations, the OR’s of having ≥3 abortions when compared to having 2 abortions were 1.515 (95% CI: 0.414-5.552), 0.573 (95% CI: 0.228-1.441), and 2.848 (95% CI: 0.355-22.871). All cases with PTm mutation had ≥3 abortions and all abortions occurred between 6-8 gestational weeks. Conclusion: Chromosomal abnormalities and thrombophilic mutations (especially PTm) seem to have an important role in RM. Additional larger studies involving investigation of more genes that may have a role in pregnancy are needed to assess this association.

Keywords: Recurrent miscarriage, chromosomal abnormalities, inherited thrombophilic polymorphisms

African Health sciences Vol 14 No. 1 March 2014